Describir: Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study.